You Are Here: Home > About Arthritis > Arthritis in the News > B.C. arthritis, diabetes patients have 6 months to switch to cheaper ‘biosimilar’ drugs

B.C. arthritis, diabetes patients have 6 months to switch to cheaper ‘biosimilar’ drugs

British Columbians on certain drugs for arthritis and diabetes will have six months to transition to equivalent less-costly drugs, as the province expands use of “biosimilars.”

The move is expected to save $96 million over the first three years.Back to News